← Search & browse all drugs
MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Propionic acid derivatives
indoprofen
M01AE10
Forms & Strengths
- Oral capsules 100 mg
- Oral tablets 200 mg
- Injectable solution 100 mg/2 mL
Adult Dosing
- Rheumatoid arthritis and osteoarthritis: 200 mg to 400 mg daily in divided doses
- Acute pain and dysmenorrhea: 100 mg to 200 mg every 6 to 8 hours as needed
- Maximum daily dose generally not to exceed 600 mg
Pediatric Dosing
- Safety and efficacy in pediatric patients have not been established
- Use in children is generally not recommended
Indications
- Management of inflammatory conditions such as rheumatoid arthritis and osteoarthritis
- Relief of mild to moderate acute pain
- Treatment of primary dysmenorrhea
Mechanism of Action
- Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes
- Reduces synthesis of pro-inflammatory prostaglandins from arachidonic acid
- Possesses analgesic, anti-inflammatory, and antipyretic properties
Contraindications
- Hypersensitivity to indoprofen or history of aspirin/NSAID-induced asthma or urticaria
- Active peptic ulcer disease or gastrointestinal bleeding
- Severe heart failure, hepatic impairment, or renal impairment
- Third trimester of pregnancy
Adverse Reactions
- Gastrointestinal: dyspepsia, nausea, abdominal pain, peptic ulceration, GI bleeding
- Central nervous system: headache, dizziness, drowsiness
- Dermatological: rash, pruritus
- Renal: fluid retention, edema, elevated serum creatinine, decreased renal function
- Hematological: prolonged bleeding time, anemia
Drug Interactions
- Anticoagulants (e.g., warfarin): increased risk of severe bleeding
- Antihypertensives and diuretics: diminished antihypertensive and diuretic efficacy; increased risk of nephrotoxicity
- Lithium and methotrexate: reduced renal clearance leading to potential toxicity
- Other NSAIDs or corticosteroids: additive gastrointestinal toxicity and ulceration risk
Curated Content: Needs Vetting Before Put to Clinical Use